These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Rheumatoid Arthritis - New Treatment Options]. Fiehn C Dtsch Med Wochenschr; 2017 Dec; 142(24):1844-1848. PubMed ID: 29207429 [No Abstract] [Full Text] [Related]
8. Deal watch : BMS acquires rights for IL-6 inhibitor. Nat Rev Drug Discov; 2010 Jan; 9(1):10. PubMed ID: 20043020 [No Abstract] [Full Text] [Related]
9. New therapeutic options in rheumatoid arthritis: a focus on interleukin-6 blockade. Furfaro N J Infus Nurs; 2011; 34(2):107-15. PubMed ID: 21399456 [TBL] [Abstract][Full Text] [Related]
10. [Tocilizumab in rheumatoid arthritis. Interleukin 6 as a new target]. Heinzl S Med Monatsschr Pharm; 2008 Dec; 31(12):450-3. PubMed ID: 19133593 [No Abstract] [Full Text] [Related]
11. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage. Prescrire Int; 2009 Oct; 18(103):198-201. PubMed ID: 19882783 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 inhibition--tolerability profile and clinical implications. Strand V; Yazici Y Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S21-4. PubMed ID: 17708741 [TBL] [Abstract][Full Text] [Related]
13. [Mechanism of action of biological disease--modifying antirheumatic drugs]. Takahashi N; Ishiguro N Nihon Rinsho; 2016 Jun; 74(6):882-6. PubMed ID: 27311173 [No Abstract] [Full Text] [Related]
14. [New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)]. Nasonov EL Ter Arkh; 2010; 82(5):64-71. PubMed ID: 20597275 [TBL] [Abstract][Full Text] [Related]
15. Tocilizumab for rheumatoid arthritis. Drug Ther Bull; 2010 Jan; 48(1):9-12. PubMed ID: 20040568 [TBL] [Abstract][Full Text] [Related]
16. [Kineret, Enbrel, Remicade and company. Recombinant drugs in rheumatoid arthritis]. Zündorf I; Dingermann T Pharm Unserer Zeit; 2003; 32(5):376-83. PubMed ID: 14526457 [No Abstract] [Full Text] [Related]
17. [Adalimumab in advanced and early rheumatoid arthritis]. Szekanecz Z Orv Hetil; 2009 Jul; 150(28):1333-4. PubMed ID: 19581162 [No Abstract] [Full Text] [Related]
18. Tocilizumab and missed personalized medicine opportunities for patients with rheumatoid arthritis? Littman BH Arthritis Rheum; 2009 May; 60(5):1565-6. PubMed ID: 19404928 [No Abstract] [Full Text] [Related]
19. Recombinant DNA product for rheumatoid arthritis. FDA Consum; 2003; 37(2):5. PubMed ID: 12715755 [No Abstract] [Full Text] [Related]